Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia and Development of Artificial Intelligence Modelling

Sponsor
Dr.dr.Irma Bernadette, SpKK (K) (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05844904
Collaborator
Indonesian Society of Dermatology and Venereology (Other), College of Dermatologist and Venereologist (Other), Indonesia Medical Education and Research Institute (Other)
1,950
13
4
150
37.4

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about the skin type of Indonesians based on Baumann Skin Type Indicator Questionnaire in Indonesian language version, and to develop artificial intelligence modelling of BSTI-Ina. The main questions it aims to answer are:

  1. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2006 version which was adapted from BSTI questionnaire in English language year 2006 version as a specific measurement to identify skin type?

  2. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2022 version which was adapted from BSTI questionnaire in English language year 2022 version as a specific measurement to identify skin type?

  3. What is the comparison of the validity and reliability between BSTI-Ina questionnaire year 2006 and year 2022 to determine Indonesian adult population's skin type?

  4. How is the mapping of Indonesians' skin type based on BSTI-Ina?

  5. What is the proportion of each skin type based on BSTI-Ina in Indonesian population?

  6. What is the proportion of each skin type based on BSTI-Ina in Indonesian population sociodemographically?

  7. How can Artificial Intelligence help categorize skin type based on BSTI-Ina automatically?

Participants are males and females between 18-59 year old. Participants will be asked to fill BSTI-Ina questionnaire. Participants then will be photographed in five different positions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This research is an observational study with a cross-sectional design. The aims of this study is to determine the validity and reliability of BSTI questionnaire translated in Indonesian and to develop artificial intelligence modelling for BSTI-Ina based on photographs. This study will be held in 13 research centers with a total of 1950 subjects consists of males and females age 18-59. It conducts of 2 phases. Phase 1 is to determine which version of BSTI will be used based on which one is more valid and reliable being translated in Indonesian and will be conducted in Jakarta as a pilot. In phase 1, participants will be asked to fill both BSTI-Ina 2006 and 2002 questionnaire. Participants then will be photographed in five different positions. Data will be analyzed to determine which of BSTI-Ina version is more valid and reliable. After deciding which BSTI-Ina version will be used, the study then goes to phase 2. Phase 2 will be conducted in 12 other research centers in Indonesia to map Indonesian population skin type. In both 2 phases, all participants will be asked to fill in BSTI-Ina questionnaire (either 2006 or 2022 version based on the result of Phase 1). Participants then will be photographed in five different positions. After all the data from all research centers are collected, data will be analyzed to map Indonesian population's skin type. Data as participants' skin types and photographs will also be processed by machine to model artificial intelligence. The aim is to automatically categorize skin type based on BSTI-Ina based on photographs.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1950 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia (BSTI-Ina) Questionnaire and Development of Artificial Intelligence Modelling BSTI-Ina: A Multicentric Study
    Anticipated Study Start Date :
    May 1, 2023
    Anticipated Primary Completion Date :
    Jul 1, 2023
    Anticipated Study Completion Date :
    Aug 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    General

    This research is an observational study. There's no control and experimental group.

    Outcome Measures

    Primary Outcome Measures

    1. Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language [Up to 2 weeks]

      Adapting Baumann Skin Type Indicator questionnaire 2006 version to Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language by certified translators

    2. Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language [Up to 2 weeks]

      Adapting Baumann Skin Type Indicator questionnaire 2022 version to Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language by certified translators

    3. More valid and reliable version of Baumann Skin Type Indicator-Ina questionnaire (2006 or 2022 version) [Up to 1 month]

      Comparing between Baumann Skin Type Indicator-Ina questionnaire 2006 version and 2022 version by statistician

    4. Mapping of Indonesian population's skin type based on Baumann Skin Type Indicator-Ina [Up to 2 months]

      Determine the proportion of Indonesia population's skin type based on Baumann Skin Type Indicator in 13 research centers

    5. Capability of artificial intelligence model to categorize skin type based on Baumann Skin Type Indicator-Ina [Up to 1 month]

      Data such as participants' skin types and photographs will be analyzed by machine resulting AI to categorize skin type automatically by photographs.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 59 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Males and females age 18-59 year old.

    • Fitzpatrick's skin type III-V

    • Educational degree of minimum high school

    • Can speak Indonesian

    • Can read

    • Willing to participate and sign informed consent

    Exclusion Criteria:
    • Participant who doesn't fill the questionnaire completely

    • Participant with skin disease involving >25% facial area

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rumah Sakit Umum Pusat Prof. Dr. I Goesti Ngoerah Gde Ngoerah Denpasar Bali Indonesia 80113
    2 Rumah Sakit Umum Pusat Dr. Kariadi Semarang Central Java Indonesia 50244
    3 Rumah Sakit Umum Daerah Dr. Moewardi Surakarta Central Java Indonesia 57126
    4 Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo Jakarta Pusat DKI Jakarta Indonesia 10430
    5 Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang East Java Indonesia 65112
    6 Rumah Sakit Umum Daerah Dr. Soetomo Surabaya East Java Indonesia 60286
    7 Rumah Sakit Umum Pusat Prof. dr. R. D. Kandou Manado North Sulawesi Indonesia 95262
    8 Rumah Sakit Universitas Sumatera Utara Medan North Sumatra Indonesia 20154
    9 Rumah Sakit Umum Pusat Dr. dr. Wahidin Sudirohusodo Makassar South Sulawesi Indonesia 90245
    10 Rumah Sakit Umum Pusat Dr. Mohammad Hoesin Palembang South Sumatra Indonesia 30126
    11 Rumah Sakit Umum Pusat Dr. Sardjito Yogyakarta Special Region Of Yogyakarta Indonesia 55281
    12 Rumah Sakit Umum Pusat Dr. Hasan Sadikin Bandung West Java Indonesia 40161
    13 Rumah Sakit Umum Pusat Dr. M. Djamil Padang West Sumatra Indonesia 25171

    Sponsors and Collaborators

    • Dr.dr.Irma Bernadette, SpKK (K)
    • Indonesian Society of Dermatology and Venereology
    • College of Dermatologist and Venereologist
    • Indonesia Medical Education and Research Institute

    Investigators

    • Principal Investigator: Irma Bernadette, MD, Faculty of Medicine, University of Indonesia
    • Study Director: Hanny Nilasari, MD, Faculty of Medicine, University of Indonesia
    • Study Director: Sandra Widaty, MD, Faculty of Medicine, University of Indonesia
    • Study Director: Nelva K Jusuf, MD, Faculty of Medicine, University of North Sumatra
    • Study Director: Puguh Riyanto, MD, Faculty of Medicine, Diponegoro University
    • Study Director: Asnawi Madjid, MD, Faculty of Medicine, Hasanuddin University
    • Study Director: Marlyn G Kapantow, MD, Faculty of Medicine, Sam Ratulangi University
    • Study Director: I Gusti Ayu A Praharsini, MD, Faculty of Medicine, Udayana University
    • Study Director: Reti Hindritiani, MD, Faculty of Medicine, Padjadjaran University
    • Study Director: Diah M Indramaya, MD, Faculty of Medicine, Airlangga University
    • Study Director: Yuli Kurniawati, MD, Faculty of Medicine, Sriwijaya University
    • Study Director: Satya W Yenny, MD, Faculty of Medicine, Andalas University
    • Study Director: Arie Kusumawardani, MD, Faculty of Medicine, Sebelas Maret University
    • Study Director: Shinta Murlistyarini, MD, Faculty of Medicine, Brawijaya University
    • Study Director: Flandiana Yogianti, MD, Faculty of Medicine, Gadjah Mada University
    • Study Director: Aria Kekalih, MD, Faculty of Medicine, University of Indonesia
    • Study Director: Prasandhya A Yusuf, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
    • Study Director: Eric D Tenda, MD, Indonesia Medical Education and Research Institute, University of Indonesia
    • Study Director: Vanya V Valindria, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
    • Study Director: Sari Chairunnisa, MD, Paragon Technology & Innovation
    • Study Director: Irwan Batubara, MD, Faculty of Medicine, University of Indonesia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr.dr.Irma Bernadette, SpKK (K), Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK(K) - Head of Cosmetic Dermatology Division, Dermatology and Venereology Department, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Indonesia University
    ClinicalTrials.gov Identifier:
    NCT05844904
    Other Study ID Numbers:
    • MappingofBSTI
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dr.dr.Irma Bernadette, SpKK (K), Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK(K) - Head of Cosmetic Dermatology Division, Dermatology and Venereology Department, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Indonesia University

    Study Results

    No Results Posted as of May 6, 2023